Biochemical markers of myocyte injury in heart failure

Heart
Yukihito SatoTakeshi Kimura

Abstract

This review discusses the role of biochemical markers of myocyte injury in patients with chronic congestive heart failure. Heart specific assays have been developed for the measurement of cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart type fatty acid binding protein (H-FABP), and myosin light chain 1 (MLC-1). Concentrations of these biochemical markers increase in the absence of ischaemic events in the subset of patients with heart failure whose long term outcomes are most adverse. The markers are easy to measure serially and it is therefore easy to follow patients without inter-observer variability. The serial clinical use of these markers, separately or in combination, will sharpen our understanding of the state of heart failure.

References

Apr 1, 1984·Journal of Molecular and Cellular Cardiology·H M PiperP G Spieckermann
Jan 20, 1998·Lancet·T A McDonaghH J Dargie
Mar 11, 1998·Lancet·R Donnelly, M W Millar-Craig
Jun 13, 1998·Archives of Internal Medicine·L Coudrey
Jun 18, 1998·American Heart Journal·M K BaigM Gheorghiade
Sep 11, 1999·The American Journal of Cardiology·K SetsutaH Hayakawa
Aug 10, 2000·Journal of the American College of Cardiology·D CardinaleC Fiorentini
Sep 12, 2000·Circulation·A S JaffeH Katus
Sep 19, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·R Latini, S Masson
Aug 9, 2001·European Heart Journal·W J RemmeUNKNOWN Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology
Feb 9, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Sharon A HuntUNKNOWN American Heart Association
May 1, 2002·Circulation·John McMurray, Marc A Pfeffer
May 3, 2002·Journal of the American College of Cardiology·Inder S AnandLloyd Fisher
Oct 26, 2002·The American Journal of Cardiology·Mark S HansenUNKNOWN Canadian PROFILE investigators
Apr 8, 2003·American Heart Journal·Yukihito SatoAkira Matsumori
Aug 2, 2003·Lancet·James A de LemosMark H Drazner

❮ Previous
Next ❯

Citations

Dec 8, 2005·Current Heart Failure Reports·Nandan S Anavekar, Nagesh S Anavekar
Feb 6, 2007·Advances in Therapy·Ahmet YilmazIzzet Tandogan
Feb 15, 2008·Internal and Emergency Medicine·Nicola ParentiFanciulli Angelo
Feb 26, 2009·European Heart Journal·Rafael VazquezUNKNOWN MUSIC Investigators
Apr 24, 2010·Journal of Veterinary Internal Medicine·G WessK Hartmann
Sep 6, 2005·American Journal of Respiratory and Critical Care Medicine·Máximo VentoJosé Viña
Jun 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Anthony S McLeanMark Salter
Nov 27, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Ryoji TaniguchiToru Kita
Jun 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuhide KuwabaraYoshiki Takatsu
Apr 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Yukiko NishioToru Kita
Jan 26, 2006·The Tohoku Journal of Experimental Medicine·Takao KatoYoshiki Takatsu
May 3, 2007·American Journal of Veterinary Research·Ryan D BaumwartKathryn M Meurs
Aug 20, 2010·Cardiology Research and Practice·Siddharth A WayangankarKaren J Beckman
Sep 1, 2009·Future Cardiology·Pericle Di Napoli, Alfonso A Taccardi
Dec 3, 2014·The American Journal of Cardiology·Sean P CollinsMihai Gheorghiade
Sep 8, 2005·European Neurology·Yoshihiro SatoKei Satoh
Oct 3, 2006·Expert Review of Molecular Diagnostics·Peter James O'Brien
Mar 13, 2012·Heart Failure Clinics·Viorel G Florea, Inder S Anand
Mar 29, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Daniela Giannessi
May 28, 2015·Journal of Molecular and Cellular Cardiology·Raymond D Devine, Loren E Wold
Nov 26, 2008·Heart Failure Clinics·Anna Marie ChangJudd E Hollander
Jul 23, 2008·Journal of Biomechanics·Jinseok KimSukho Park
May 27, 2015·International Journal of Cardiology·Justyna RybickaPiotr Szymański
Aug 24, 2005·Journal of Internal Medicine·M KupariK Pettersson
Dec 4, 2012·Clinical and Experimental Immunology·Y ZhangF Gao
Apr 9, 2014·Emergency Medicine Australasia : EMA·Atifur Rahman, Simon A Broadley
Sep 27, 2005·The American Journal of Cardiology·Mihai GheorghiadeChristopher M O'Connor
May 27, 2015·Genesis : the Journal of Genetics and Development·Jianyun YanChen-Leng Cai
Sep 25, 2010·Journal of the American College of Cardiology·Robb D KociolG Michael Felker
Oct 24, 2009·Journal of the American College of Cardiology·Wayne L MillerAllan S Jaffe
Aug 8, 2012·Journal of cardiology·Yukihito SatoYoshiki Takatsu
Mar 19, 2013·International Journal of Cardiology·Genzou TakemuraHisayoshi Fujiwara
Sep 3, 2011·Journal of cardiology·Yukihito SatoYoshiki Takatsu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.